ROIV logo

ROIV
Roivant Sciences Ltd

1,998
Mkt Cap
$19.92B
Volume
4.23M
52W High
$30.33
52W Low
$10.58
PE Ratio
-23.82
ROIV Fundamentals
Price
$27.83
Prev Close
$28.53
Open
$28.79
50D MA
$28.29
Beta
0.95
Avg. Volume
5.02M
EPS (Annual)
-$0.2371
P/B
4.63
Rev/Employee
$38,737.33
$3,029.76
Loading...
Loading...
News
all
press releases
Sandro Wealth Management LLC Invests $1.96 Million in Roivant Sciences Ltd. $ROIV
Sandro Wealth Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 90,267 shares of the company's stock, va...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Jennison Associates LLC Invests $51.07 Million in Roivant Sciences Ltd. $ROIV
Jennison Associates LLC bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange...
MarketBeat·3d ago
News Placeholder
Pictet Asset Management Holding SA Raises Holdings in Roivant Sciences Ltd. $ROIV
Pictet Asset Management Holding SA lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 790.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,312,436 shares of the company's stock after purchasing...
MarketBeat·4d ago
News Placeholder
UBS Group AG Grows Stock Holdings in Roivant Sciences Ltd. $ROIV
UBS Group AG raised its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 570.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,390,792 shares of the company's stock after buying an additional 1...
MarketBeat·6d ago
News Placeholder
Roivant Sciences Ltd. $ROIV Stake Cut by Impax Asset Management Group plc
Impax Asset Management Group plc reduced its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 69.4% in the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
M&T Bank Corp Takes Position in Roivant Sciences Ltd. $ROIV
M&T Bank Corp bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·9d ago
News Placeholder
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $29.59, for...
MarketBeat·11d ago
News Placeholder
Roivant Sciences (NASDAQ:ROIV) CEO Matthew Gline Sells 289,774 Shares
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Matthew Gline sold 289,774 shares of the firm's stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an...
MarketBeat·13d ago
News Placeholder
Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Rating of "Moderate Buy" by Brokerages
Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the stock, MarketBeat Ratings reports. One...
MarketBeat·19d ago
News Placeholder
Elevate Capital Advisors LLC Sells 36,236 Shares of Roivant Sciences Ltd. $ROIV
Elevate Capital Advisors LLC cut its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 31.8% during the 4th quarter, according to its most recent 13F filing with the Securities...
MarketBeat·22d ago
<
1
2
...
>

Latest ROIV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.